# American Natl. Red Cross-Greater Chesapeake & Potomac Region, Baltimore, MD – FDA Inspections

Source: https://www.keypedia.com/companies/american-natl-red-cross-greater-chesapeake-potomac-region/aedf322a-3642-48f6-a582-7d897fc96eec

> Inspection records and compliance data for American Natl. Red Cross-Greater Chesapeake & Potomac Region in Baltimore, Maryland. 12 FDA inspections on record, last inspected July 16, 2026.

---

## Details

- Name: American Natl. Red Cross-Greater Chesapeake & Potomac Region
- FEI Number: 1173011
- Facility Type: Blood Bank
- Address Line 1: 4700 Mount Hope Dr
- City: Baltimore
- State: Maryland
- Zip Code: 21215
- Country Name: United States
- Address: 4700 Mount Hope Dr, Baltimore, Maryland 21215, United States
- Country: United States

## Related Documents

- FDA Inspection 1331938 - American Natl. Red Cross-Greater Chesapeake & Potomac Region - 2026-07-16 — source: FDA, date: July 16, 2026
- FDA Inspection 1180888 - American Natl. Red Cross-Greater Chesapeake & Potomac Region - 2022-09-12 — classification: No Action Indicated (NAI), source: FDA, date: September 12, 2022
- FDA Inspection 1180888 - American Natl. Red Cross-Greater Chesapeake & Potomac Region - 2022-09-12 — classification: No Action Indicated (NAI), source: FDA, date: September 12, 2022
- FDA Inspection 1062854 - American Natl. Red Cross-Greater Chesapeake & Potomac Region - 2018-07-26 — classification: No Action Indicated (NAI), source: FDA, date: July 26, 2018
- FDA Inspection 1072133 - American Natl. Red Cross-Greater Chesapeake & Potomac Region - 2018-07-25 — source: FDA, date: July 25, 2018
- FDA Inspection 983629 - American Natl. Red Cross-Greater Chesapeake & Potomac Region - 2016-09-01 — classification: No Action Indicated (NAI), source: FDA, date: September 1, 2016
- [FDA Inspection 943997 - American Natl. Red Cross-Greater Chesapeake & Potomac Region - 2015-10-01](https://www.keypedia.com/records/fda_inspections/american-natl-red-cross-greater-chesapeake-potomac-region/4ba1b88e-0fd0-4833-abc7-9c8e66d93ab9) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 1, 2015
- [FDA Inspection 895857 - American Natl. Red Cross-Greater Chesapeake & Potomac Region - 2014-10-03](https://www.keypedia.com/records/fda_inspections/american-natl-red-cross-greater-chesapeake-potomac-region/1b015554-9b0e-479f-b154-c58764a14b42) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 3, 2014
- FDA Inspection 852154 - American Natl. Red Cross-Greater Chesapeake & Potomac Region - 2013-09-30 — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 30, 2013
- FDA Inspection 815026 - American Natl. Red Cross-Greater Chesapeake & Potomac Region - 2013-01-25 — classification: No Action Indicated (NAI), source: FDA, date: January 25, 2013
- ADVERSE_DETERMINATION_LETTER - American Natl. Red Cross-Greater Chesapeake & Potomac Region - 2012-03-14 — source: FDA, date: March 14, 2012
- ADVERSE_DETERMINATION_LETTER - American Natl. Red Cross-Greater Chesapeake & Potomac Region - 2012-02-27 — source: FDA, date: February 27, 2012
- ADVERSE_DETERMINATION_LETTER - American Natl. Red Cross-Greater Chesapeake & Potomac Region - 2010-10-29 — source: FDA, date: October 29, 2010
- ADVERSE_DETERMINATION_LETTER - American Natl. Red Cross-Greater Chesapeake & Potomac Region - 2010-10-29 — source: FDA, date: October 29, 2010
- [483 - American Natl. Red Cross-Greater Chesapeake & Potomac Region - 2008-06-23](https://www.keypedia.com/records/483/american-natl-red-cross-greater-chesapeake-potomac-region/c782f222-7202-4976-b36b-dfaa27b99a1c) — source: FDA, date: June 23, 2008
- ADVERSE_DETERMINATION_LETTER - American Natl. Red Cross-Greater Chesapeake & Potomac Region - 2005-05-16 — source: FDA, date: May 16, 2005
- ADVERSE_DETERMINATION_LETTER - American Natl. Red Cross-Greater Chesapeake & Potomac Region - 2003-09-01 — source: FDA, date: September 1, 2003

## Related Companies

- [Berkeley Biologics LLC](https://www.keypedia.com/companies/berkeley-biologics-llc/a6e5270d-1ca1-40d3-830d-422cf9cb6f58)
- [Rapa Therapeutics LLC](https://www.keypedia.com/companies/rapa-therapeutics-llc/d6777b24-b9c7-47cd-b93c-9d2703ce8592)
- [CSL Plasma Inc.](https://www.keypedia.com/companies/csl-plasma-inc/94a93e1f-ffe1-47a0-b454-e895fc5db702)
- [BioLife Plasma Services L.P.](https://www.keypedia.com/companies/biolife-plasma-services-lp/55dbebdb-5fd4-4268-a9d0-cca791444077)
- [Ira L. Berger, M.D.](https://www.keypedia.com/companies/ira-l-berger-md/f7bcfbb7-711e-43e4-abaa-c1cb7df4637a)
- [Vitalant](https://www.keypedia.com/companies/vitalant/45cab940-cb7c-41c3-bda5-aa5ae43b1fe8)
- [Incinta Fertility Center, LLC](https://www.keypedia.com/companies/incinta-fertility-center-llc/36046ca3-cebe-4278-bd85-191c0df0715e)
- [Octapharma Plasma Inc](https://www.keypedia.com/companies/octapharma-plasma-inc/948e6257-d6a8-4bd2-9bfe-9f5bde6829ce)
- [Mediwest Specialty Distribution LLC](https://www.keypedia.com/companies/mediwest-specialty-distribution-llc/29f7f9ad-7973-464d-b361-18cb82c35333)
- [KEDPLASMA LLC](https://www.keypedia.com/companies/kedplasma-llc/ae33cabf-3171-4b60-b70a-48618a540c1c)

## Related Officers

- [Investigator](https://www.keypedia.com/people/linda-s-mattingly/4abdc255-a72e-475f-b3e3-1b68bf94d3b8)
- [Kay Crull](https://www.keypedia.com/people/kay-crull/473bf59c-b949-402c-ab83-b99dd28ff6ca)
- [Director -  - Ex-FDA](https://www.keypedia.com/people/mary-a-malarkey/11b99e21-5f75-4b61-83bc-d140e35e4dae)
- [Jesse Goodman](https://www.keypedia.com/people/jesse-goodman/c9e3ea60-8bea-44ee-a6a5-1679271e90aa)
- [Investigator](https://www.keypedia.com/people/tonia-f/d6eff9ae-92f4-408e-99af-eca7704a33db)
